Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept PK in Pediatric Kidney Transplant
NCT01791491Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2013
- Primary completion
- Dec 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of belatacept in kidney transplant rejection, sponsored by Bristol Myers Squibb. Started May 2013; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01791491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791491.